DYNE THERAPEUTICS INC (DYN)

US26818M1080 - Common Stock

15  -0.29 (-1.9%)

After market: 15 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
N/AN/AN/AN/A
1,825.31%		N/A
255.27%		N/A
108.31%		N/A
52.96%		N/A
36.47%		N/A
19.33%
EBITDA
YoY % growth
-4.78M-13.56M
-183.68%		-57.95M
-327.36%		-148.94M
-157.01%		-169.28M
-13.66%		-240.489M
-42.07%		N/A
-36.67%		N/A
-14.53%		N/A
-4.15%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-4.8M-13.83M
-188.13%		-58.65M
-324.08%		-150.03M
-155.81%		-170.96M
-13.95%		-242.162M
-41.65%		N/A
-45.11%		N/A
-21.79%		N/A
-7.12%		N/A
14.71%		N/A
61.04%		N/A
256.98%		N/A
138.64%		N/A
67.14%		N/A
27.48%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A-2.91
-15.59%		-3.24
-11.34%		-3.94
-21.60%		N/A
10.35%		N/A
-10.42%		N/A
-0.05%		N/A
23.33%		N/A
30.63%		N/A
130.17%		N/A
375.40%		N/A
76.51%		N/A
33.40%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.97
11.35%		-0.94
-15.96%		-0.99
-42.12%		-1.02
-6.26%		-1.08
-11.85%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-90.9M
-37.70%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-104.792M
-54.82%		-104.103M
-50.53%		-109.333M
-51.93%		-115.533M
-9.35%		-122.808M
-17.19%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.96
3.03%		-0.72-0.24-33.50%
Q2 2024
Q2Q % growth		 -0.70
35.19%		-0.730.033.47%
Q1 2024
Q2Q % growth		 -0.81
-3.85%		-0.810.00-0.25%
Q4 2023
Q2Q % growth		 -1.09
-47.30%		-0.93-0.16-17.73%
Q3 2023
Q2Q % growth		 -0.99
-23.75%		-0.84-0.15-17.74%
Q2 2023
Q2Q % growth		 -1.08
-6.93%		-0.82-0.26-32.42%
Q1 2023
Q2Q % growth		 -0.78
-13.04%		-0.780.00-0.46%
Q4 2022
Q2Q % growth		 -0.74
26.00%		-0.850.1113.29%
Q3 2022
Q2Q % growth		 -0.80
3.61%		-0.930.1314.06%
Q2 2022
Q2Q % growth		 -1.01
-74.14%		-0.78-0.23-29.03%
Q1 2022
Q2Q % growth		 -0.69
-38.00%		-0.890.2022.59%
Q4 2021
Q2Q % growth		 -1.00
-56.25%		-1.000.00-0.01%
Q3 2021
Q2Q % growth		 -0.83
58.71%		-0.65-0.18-27.41%
Q2 2021
Q2Q % growth		 -0.58 -0.55-0.03-5.37%
Q1 2021
Q2Q % growth		 -0.50 -0.610.1117.77%
Q4 2020
Q2Q % growth		 -0.64 -0.38-0.26-70.34%
Q3 2020
Q2Q % growth		 -2.01 -0.88-1.13-127.44%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -30.16% -1.57% -16.58%
RevenueN/A N/A N/A N/A